Your browser doesn't support javascript.
loading
A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells.
Wang, Xiaoli; Haylock, David; Hu, Cing Siang; Kowalczyk, Wioleta; Jiang, Tianbo; Qiu, Jiajing; Mosoyan, Goar; He, Wu; Marshall, Netonia; Mascarenhas, John; Tarasova, Anna; Brody, Joshua; Winkler, David; Hoffman, Ronald.
Afiliação
  • Wang X; Division of Hematology/Oncology, The Tisch Cancer Institute, Department of Medicine, Myeloproliferative Disorders Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Haylock D; Commonwealth Scientific and Industrial Research Organization, Clayton, VIC, Australia;
  • Hu CS; Division of Hematology/Oncology, The Tisch Cancer Institute, Department of Medicine, Myeloproliferative Disorders Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Kowalczyk W; Commonwealth Scientific and Industrial Research Organization, Clayton, VIC, Australia;
  • Jiang T; Division of Hematology/Oncology, The Tisch Cancer Institute, Department of Medicine, Myeloproliferative Disorders Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Qiu J; Division of Hematology/Oncology, The Tisch Cancer Institute, Department of Medicine, Myeloproliferative Disorders Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Mosoyan G; Division of Hematology/Oncology, The Tisch Cancer Institute, Department of Medicine, Myeloproliferative Disorders Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY;
  • He W; Flow Cytometry Shared Resource Facility, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Marshall N; Division of Hematology/Oncology, The Tisch Cancer Institute, Department of Medicine, Myeloproliferative Disorders Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Mascarenhas J; Division of Hematology/Oncology, The Tisch Cancer Institute, Department of Medicine, Myeloproliferative Disorders Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Tarasova A; Commonwealth Scientific and Industrial Research Organization, Clayton, VIC, Australia;
  • Brody J; Division of Hematology/Oncology, The Tisch Cancer Institute, Department of Medicine, Myeloproliferative Disorders Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY;
  • Winkler D; Commonwealth Scientific and Industrial Research Organization, Clayton, VIC, Australia; Monash Institute of Pharmaceutical Sciences, Parkville, VIC, Australia; La Trobe Institute for Molecular Science, Bundoora, VIC, Australia; and School of Chemical and Physical Sciences, Flinders University, Bedfor
  • Hoffman R; Division of Hematology/Oncology, The Tisch Cancer Institute, Department of Medicine, Myeloproliferative Disorders Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY;
Blood ; 127(26): 3398-409, 2016 06 30.
Article em En | MEDLINE | ID: mdl-27114459
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Hematopoéticas / Receptores de Trombopoetina / Mielofibrose Primária Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Hematopoéticas / Receptores de Trombopoetina / Mielofibrose Primária Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article